MedPath

HEMORRO-DOL ONT

HEMORRO-DOL ONT

Discontinued
DIN Number

00540900

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

produits francais labs inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00540900
AIG Number0803848001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
C05AD03 BENZOCAINE
Product Specifications
Dosage FormOintment
Route of AdministrationRectal
AHFS Classification84:08.00
Health Canada Classification

ACTIVE INGREDIENTS (8)

ALLANTOINActive
Strength: .1 %
Monograph: ALLANTOIN
BELLADONNAActive
Strength: .45 %
Monograph: BELLADONNA
BENZOCAINEActive
Strength: 2 %
Monograph: BENZOCAINE
BISMUTH SUBCARBONATE (OXYCARBONATE)Active
Strength: 5 %
Monograph: BISMUTH SUBCARBONATE (OXYCARBONATE)
BISMUTH SUBNITRATEActive
Strength: 1.5 %
Monograph: BISMUTH SUBNITRATE
EPHEDRINE SULFATEActive
Strength: .1 %
Monograph: EPHEDRINE SULFATE
PERUVIAN BALSAMActive
Strength: 1 %
Monograph: PERUVIAN BALSAM
ZINC OXIDEActive
Strength: 5 %
Monograph: ZINC OXIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.